More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, ...

A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has ...

The MI Cancer Seek in vitro diagnostic examines genetic material isolated from standard tumor tissue specimens and queries ...

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes Project.

The CyBio FeliX, a benchtop instrument for automated liquid handling tasks, was used to automate the HaloPlex Target ...

MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...

Concurrent DNA and RNA sequencing revealed 15.3% more patients with actionable variants than DNA sequencing alone.

Scientists have identified new gene faults and evolutionary patterns contributing to testicular cancer. Their findings offer profound insights into the development of the disease and into potential ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

This collaboration will drive advancements in cancer and hereditary disease diagnostics, spanning from Whole Genome Sequencing (WGS) to Pharmacogenomics (PGx). Bumrungrad International Hospital is ...

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...